Report cover image

Sprycel Market

Publisher Coherent Market Insights
Published Jul 20, 2023
Length 150 Pages
SKU # CMI18107946

Description

Sprycel Market, By Demographic (Age, Gender, Income), By Geographic (Region, Country), By Psychographic (Lifestyle, Attitudes), By Behavioral (Usage Rate, Compliance, Treatment History), By Medical (Indication, Disease Stage), And By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030


Sprycel is a targeted medication used to treat some kinds of leukemia, such as acute lymphoblastic leukemia (ALL) with a positive Philadelphia chromosome (Ph+ ALL) and chronic myeloid leukemia (CML). Sprycel is used to treat adults and children ages 12 months and older with chronic myeloid leukaemia (CML). It is also used to treat adults and children ages 12 months and older who have a particular form of acute lymphoblastic leukaemia (ALL) called Philadelphia chromosome positive or Ph+ ALL. Leukaemia is a cancer of immature white blood cells, which grow in the bone marrow. Under normal circumstances, as these white blood cells mature, they enter the blood stream where they fight infection and maintain the body's immune system.

Market Dynamics:

Increasing prevalence of targeted indications, efficacy and safety profile, expanded indications, innovative advancements are major factors expected to drive growth of the global sprycel market during the forecast period.

However, strong competition, patent expiration, regulatory challenges, adverse effects and pricing and reimbursement is/are expected to hamper the growth of the global sprycel market market over the forecast period.

Key features of the study:
  • This report provides in-depth analysis of the global sprycel market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global sprycel market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Bristol-Myers Squibb (BMS), Novartis, Teva Pharmaceutical Industries, Mylan, Accord Healthcare, Sun Pharma, Dr. Reddy's Laboratories, Aurobindo Pharma
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global sprycel market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global sprycel market.
Detailed Segmentation:
  • Global Sprycel Market By Demographic:
  • Age
  • Gender
  • Income
  • Global Sprycel Market By Psychographic:
  • Lifestyle
  • Attitudes
  • Global Sprycel Market By Behavioral:
  • Usage Rate
  • Compliance
  • Treatment History
  • Global Sprycel Market By Medical:
  • Indication
  • Disease Stage
  • Global Sprycel Market By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
  • Company Profiles:
  • Bristol-Myers Squibb (BMS)
  • Novartis
  • Teva Pharmaceutical Industries
  • Mylan
  • Accord Healthcare
  • Sun Pharma
  • Reddy's Laboratories
  • Aurobindo Pharma

Table of Contents

150 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Demographic
Market Snapshot, By Psychographic
Market Snapshot, By Behavioral
Market Snapshot, By Medical
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Increasing prevalence of targeted indications, efficacy and safety profile, expanded indications
Strong competition, patent expiration, regulatory challenges
Innovative advancements
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Global Sprycel Market – Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Global Sprycel Market, By Demographic, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 - 2030
Segment Trends
Age
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Gender
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Income
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
6. Global Sprycel Market, By Psychographic, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2018 - 2030
Segment Trends
Lifestyle
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Attitudes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
7. Global Sprycel Market, By Behavioral, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2018 - 2030
Segment Trends
Usage Rate
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Compliance
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Treatment History
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
8. Global Sprycel Market, By Medical, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2018 - 2030
Segment Trends
Indication
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Disease Stage
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
9. Global Sprycel Market, By Region, 2023-2030, (US$ Bn)
Introduction
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2018 - 2030
Segment Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Demographic, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Psychographic, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Behavioral, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Medical, 2023-2030,(US$ Bn)
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Demographic, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Psychographic, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Behavioral, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Medical, 2023-2030,(US$ Bn)
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Demographic, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Psychographic, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Behavioral, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Medical, 2023-2030,(US$ Bn)
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Demographic, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Psychographic, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Behavioral, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Medical, 2023-2030,(US$ Bn)
Middle East & Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Demographic, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Psychographic, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Behavioral, 2023-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Medical, 2023-2030,(US$ Bn)
10. Competitive Landscape
Bristol-Myers Squibb (BMS)
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Novartis
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Teva Pharmaceutical Industries
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Mylan
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Accord Healthcare
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Sun Pharma
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Reddy's Laboratories
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Aurobindo Pharma
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Analyst Views
11. Section
Research Methodology
About us
*Browse 24 market data tables and 28 figures on "Global Sprycel Market” - forecast to 2030

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us